FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Consumer Health Theraflu Nighttime Warming Relief Nighttime Recall

Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg , C…

Novartis Consumer Health · Lincoln, NE

Risk level
Class III
Reported by FDA
Jan 22, 2014
Recall ID
D-743-2014
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled Theraflu Nighttime Warming Relief Nighttime starting May 15, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-743-2014 on Jan 22, 2014. Reason: Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.

Product description

Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg , Chlorpheniramine Maleate 2mg , Dextromethorphan HBr 10mg , Phenylephrine HCL 5mg, a) 8 coated caplets (NDC 0067-6437-08) b) 24 coated caplets (NDC 0067-6438-24). Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622.

Lot numbers, UPCs & expiration codes

a) 08 caplets: Lot# 10121222 exp 07/13. b) 24 caplets: Lot# 10117231 exp 06/13 Lot# 10117814 exp 06/13 Lot# 10119341 exp 07/13 Lot# 10123425 exp 08/13 Lot# 10124156 exp 10/13

Where it was sold

Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-743-2014
Classification
Class III
Status
Terminated
Recall initiated
May 15, 2013
FDA report date
Jan 22, 2014
Quantity
3,768/8-caplet packages and 300,580/24-caplet packages
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-743-2014, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
65181
Address
10401 Hwy 6
Code information
a) 08 caplets: Lot# 10121222 exp 07/13. b) 24 caplets: Lot# 10117231 exp 06/13 Lot# 10117814 exp 06/13 Lot# 10119341 exp 07/13 Lot# 10123425 exp 08/13 Lot# 10124156 exp 10/13
Postal code
68517-9626
Report date
Jan 22, 2014
Product type
Drugs
Recall number
D-743-2014
Classification
Class III
Recalling firm
Novartis Consumer Health
Product quantity
3,768/8-caplet packages and 300,580/24-caplet packages
Termination date
Nov 4, 2014
Reason for recall
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen 325mg , Chlorpheniramine Maleate 2mg , Dextromethorphan HBr 10mg , Phenylephrine HCL 5mg, a) 8 coated caplets (NDC 0067-6437-08) b) 24 coated caplets (NDC 0067-6438-24). Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622.
Distribution pattern
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Recall initiation date
May 15, 2013
Initial firm notification
Letter
Center classification date
Jan 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-743-2014, published Jan 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls